Ayman Maher Nagib Selected Research

Ayman Maher Nagib Research Topics

2	Body Weight (Weight, Body) 01/2022 - 08/2015
1	Hyperkalemia 01/2022
1	Drug Hypersensitivity (Drug Allergy) 03/2021
1	Diabetes Mellitus 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Hepatitis B 10/2015
1	Hypercholesterolemia 08/2015
1	Insulin Resistance 08/2015
1	Proteinuria 08/2015
1	Delayed Graft Function 03/2014

2	Pharmaceutical PreparationsIBA 01/2022 - 03/2021
1	Calcineurin InhibitorsIBA 01/2022
1	FludrocortisoneIBA 01/2022
1	PotassiumIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Sulfamethoxazole FDA LinkGeneric 01/2022
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2022
1	Essential DrugsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2015
1	ApelinIBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015

1	Glycemic Control 01/2019
1	Therapeutics 03/2014